Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth

Wen Yang(West China Medical Center of Sichuan University), Yang Qin(West China Medical Center of Sichuan University), Wen Huang(Beijing University of Chemical Technology), Wen Shen(West China Medical Center of Sichuan University), Bo Li(Jinzhou Medical University), Ran Li(Shanghai Jiao Tong University), Ling Wei(West China Medical Center of Sichuan University), Jian Yu Liu, Jian Xu(University of California, Los Angeles)
Oncology Reports
March 24, 2014
10.3892/or.2014.3111
Cited by 29

Related Papers

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Targeted Therapy against Metastatic Melanoma Based on Self‐Assembled Metal‐Phenolic Nanocomplexes Comprised of Green Tea Catechin
|Advanced Science|2019|180